Ronald Kirk Huntsman - Jun 20, 2024 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role
Chief Executive Officer, Director
Signature
/s/ Bradford K. Amman as attorney-in-fact for Ronald Kirk Huntsman
Stock symbol
VVOS
Transactions as of
Jun 20, 2024
Transactions value $
$47,600
Form type
4
Date filed
6/28/2024, 08:53 PM
Previous filing
Jun 20, 2023
Next filing
Nov 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VVOS Common Stock 3.46K Jun 20, 2024 Direct
holding VVOS Common Stock 69.6K Jun 20, 2024 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VVOS Stock Option (Right to Buy) Award $47.6K +20K +68.18% $2.38 49.3K Jun 20, 2024 Common Stock 20K $2.38 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Coronado V Partners, LLC, of which the Reporting Person is a member and manager.
F2 On June 20, 2024 (the "Grant Date"), the Reporting Person received a grant of 20,000 stock options from the Issuer. One-fifth vested immediately and one-fifth will vest annually on each anniversary of the Grant Date through June 20, 2028.